Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-14 12:31 pm Sale | 13G | HAVARD BIOSCIENCE INC HBIO | 272 Capital LP | 1,555,820 3.600% | -1,383,458 (-47.07%) | View |
2024-11-14 12:30 pm Purchase | 13G | CADIZ INC CDZI | 272 Capital LP | 3,522,582 5.200% | 3,522,582 (New Position) | View |
2024-02-14 08:48 am Sale | 13G | ARENA GROUP HLDGS INC DEL COM AREN | 272 Capital LP | 0 0.000% | -1,654,698 (Position Closed) | View |
2024-02-14 08:46 am Sale | 13G | HAVARD BIOSCIENCE INC HBIO | 272 Capital LP | 2,939,278 6.900% | -325,518 (-9.97%) | View |
2023-10-27 4:30 pm Purchase | 13D | SEQUANS COMMUNICATIONS S A SQNS | 272 Capital LP | 45,013,764 18.500% | 25,143,216 (+126.54%) | View |
2023-02-16 3:13 pm Unchanged | 13G | ARENA GROUP HLDGS INC DEL COM AREN | 272 Capital LP | 1,654,698 9.100% | 0 (Unchanged) | View |
2023-02-16 3:11 pm Unchanged | 13G | HAVARD BIOSCIENCE INC HBIO | 272 Capital LP | 3,264,796 7.800% | 0 (Unchanged) | View |
2023-02-15 5:37 pm Sale | 13G | INTEST CORPORATION INTT | 272 Capital LP | 0 0.000% | -836,918 (Position Closed) | View |
2023-02-15 5:30 pm Purchase | 13G | HAVARD BIOSCIENCE INC HBIO | 272 Capital LP | 3,264,796 7.840% | 3,264,796 (New Position) | View |
2023-02-15 5:27 pm Purchase | 13G | ARENA GROUP HLDGS INC DEL COM AREN | 272 Capital LP | 1,654,698 9.070% | 1,654,698 (New Position) | View |
2022-12-05 5:14 pm Purchase | 13D | SEQUANS COMMUNICATIONS S A SQNS | 272 Capital LP | 19,870,548 10.400% | 2,083,200 (+11.71%) | View |
2022-10-18 5:01 pm Purchase | 13D | CAMP4 THERAPEUTICS CORP COM CAMP | 272 Capital LP | 3,126,959 8.440% | 897,800 (+40.28%) | View |
2022-09-06 5:00 pm Purchase | 13D | SEQUANS COMMUNICATIONS S A SQNS | 272 Capital LP | 17,787,348 9.300% | 3,374,016 (+23.41%) | View |
2022-07-22 4:15 pm Purchase | 13D | CAMP4 THERAPEUTICS CORP COM CAMP | 272 Capital LP | 2,229,159 6.170% | 853,694 (+62.07%) | View |
2022-06-22 5:00 pm Purchase | 13D | CAMP4 THERAPEUTICS CORP COM CAMP | 272 Capital LP | 1,375,465 3.810% | 20,787 (+1.53%) | View |
2022-05-26 3:26 pm Purchase | 13D | CAMP4 THERAPEUTICS CORP COM CAMP | 272 Capital LP | 1,354,678 3.760% | 1,354,678 (New Position) | View |
2022-03-24 12:11 pm Purchase | 13D | SEQUANS COMMUNICATIONS S A SQNS | 272 Capital LP | 14,413,332 8.100% | 14,413,332 (New Position) | View |
2021-01-20 11:44 am Purchase | 13G | INTEST CORPORATION INTT | 272 Capital LP | 836,918 7.900% | 836,918 (New Position) | View |